Catch this AlphaNooner replay featuring Doug Drysdale, CEO of Cybin ($CYBN). Doug dives into Cybin's latest progress on psychedelic therapeutics, including key updates on CYB003 and CYB004, insights into the evolving biotech landscape, and why he's optimistic about the future of mental health treatments.
Episode 6